OSCR

Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods.

A correction to this paper has been published: the notice, 42768843, from Europe PMC.

Overview

Authors: Kohichi Go1, Asako Katsuma2, Ema Yoshioka2, Tomoko Shofuda2, Kohei Fukuoka3, Koichi Ichimura4, Yuko Matsushita4, Yohei Mineharu1, Yasuhide Makino1, Takeshi Kawauchi1, Atsushi Sasaki5, Junko Hirato6, Takeshi Inoue7, Yoshinori Kodama8,9, Masayuki Mano8, Daisuke Kanematsu2, Noriyuki Kijima10, Naoki Kagawa10,11, Dai Keino12, Akitake Mukasa13
and 51 other authorsTomonari Suzuki14, Koji Yoshimoto15, Daisuke Kuga15, Keishi Horiguchi16, Shigeru Yamaguchi17, Masayuki Kanamori18, Kai Yamasaki19, Kenichi Ishibashi20, Takuya Akai21, Masayoshi Yamaoka22, Ryuji Ishizaki23, Atsufumi Kawamura24, Shigeo Ohba25, Joji Ishida26, Ryo Ando27, Junya Fukai28, Tomoru Miwa29, Masazumi Fujii30, Ai Muroi31, Kuniaki Saito32, Atsuko Harada33, Yasuhiko Hayashi34, Masahiro Nonaka35, Young‐Soo Park36, Yusuke Kobayashi37, Tadashi Higuchi38, Yosuke Miyairi39, Kazuhisa Yoshifuji40, Noriyoshi Takebe41, Soichi Oya42, Kosuke Nakajo43, Mitsutoshi Nakada44, Yoshiteru Nakano45, Mizuki Kambara46, Koji Adachi47, Kazuhiro Tanaka48, Hideo Nakamura49, Yukihiko Sonoda50, Ryuta Saito51, Takafumi Wataya52, Kazuhiko Kurozumi53, Michael D Taylor54,55,56,57,58,59,60,61,62, Yoshitaka Narita63, Soichiro Shibui64, Hajime Arai65, Hiroaki Sakamoto43,66, Isao Date26, Motoo Nagane32, Ryo Nishikawa14, Yoshiki Arakawa1, Yonehiro Kanemura2,67
67 affiliations
  1. Department of Neurosurgery, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan
  2. Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan
  3. Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan
  4. Department of Pathology, Kyorin University Faculty of Medicine, Tokyo, Japan
  5. Department of Pathology, Saitama Medical University, Saitama, Japan
  6. Department of Pathology, Public Tomioka General Hospital, Gunma, Japan
  7. Department of Pathology, Osaka City General Hospital, Osaka, Japan
  8. Department of Central Laboratory and Surgical Pathology, NHO Osaka National Hospital, Osaka, Japan
  9. Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan
  10. Department of Neurosurgery, The University of Osaka Graduate School of Medicine, Osaka, Japan
  11. Department of Neurosurgery, Yukioka Hospital, Osaka, Japan
  12. Division of Hematology/Oncology, Kanagawa Children's Medical Center, Kanagawa, Japan
  13. Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
  14. Department of Pediatric Neuro‐Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan
  15. Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
  16. Department of Neurosurgery, Gunma University Graduate School of Medicine, Gunma, Japan
  17. Department of Neurosurgery, Hokkaido University Graduate School of Medicine, Hokkaido, Japan
  18. Department of Neurosurgery, Tohoku University Graduate School of Medicine, Miyagi, Japan
  19. Department of Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan
  20. Department of Neurosurgery, Osaka City General Hospital, Osaka, Japan
  21. Department of Neurosurgery, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan
  22. Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan
  23. Department of Neurosurgery, Shizuoka Children's Hospital, Shizuoka, Japan
  24. Department of Neurosurgery, Hyogo Prefectural Kobe Children's Hospital, Hyogo, Japan
  25. Department of Neurosurgery, Fujita Health University School of Medicine, Aichi, Japan
  26. Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
  27. Department of Neurosurgery, Chiba Children's Hospital, Chiba, Japan
  28. Department of Neurological Surgery, Wakayama Medical University School of Medicine, Wakayama, Japan
  29. Department of Neurosurgery, Keio University School of Medicine, Tokyo, Japan
  30. Department of Neurosurgery, Fukushima Medical University, Fukushima, Japan
  31. Department of Neurosurgery, Institute of Medicine, University of Tsukuba, Ibaraki, Japan
  32. Department of Neurosurgery, Kyorin University School of Medicine, Tokyo, Japan
  33. Department of Pediatric Neurosurgery, Takatsuki General Hospital, Osaka, Japan
  34. Department of Neurosurgery, Kanazawa Medical University, Ishikawa, Japan
  35. Department of Neurosurgery, Kansai Medical University, Osaka, Japan
  36. Department of Neurosurgery and Children's Medical Center, Nara Medical University, Nara, Japan
  37. Department of Neurosurgery, Showa Medical University School of Medicine, Tokyo, Japan
  38. Department of Neurological Surgery, Nippon Medical School, Tokyo, Japan
  39. Department of Neurosurgery, Nagano Children's Hospital, Nagano, Japan
  40. Division of Pediatric Neurosurgery, Hokkaido Medical Center for Child Health and Rehabilitation, Hokkaido, Japan
  41. Department of Neurosurgery, Medical Research Institute Kitano Hospital, PIIF Tazuke‐kofukai, Osaka, Japan
  42. Department of Neurosurgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan
  43. Department of Neurosurgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
  44. Department of Neurosurgery, Graduate School of Medical Science, Kanazawa University, Ishikawa, Japan
  45. Department of Neurosurgery, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan
  46. Department of Neurosurgery, Shimane University Faculty of Medicine, Shimane, Japan
  47. Department of Neurological Surgery, Nippon Medical School, Musashi‐Kosugi Hospital, Kanagawa, Japan
  48. Department of Neurosurgery, Kobe University Graduate School of Medicine, Hyogo, Japan
  49. Department of Neurosurgery, Kurume University School of Medicine, Fukuoka, Japan
  50. Department of Neurosurgery, Yamagata University Faculty of Medicine, Yamagata, Japan
  51. Department of Neurosurgery, Nagoya University, Graduate School of Medicine, Aichi, Japan
  52. Department of Neurosurgery, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan
  53. Department of Neurosurgery, Hamamatsu University School of Medicine, Shizuoka, Japan
  54. Texas Children's Cancer and Hematology Center, Houston, Texas, USA
  55. Department of Pediatrics–Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA
  56. Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA
  57. Department of Neurosurgery, Texas Children's Hospital, Houston, Texas, USA
  58. Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA
  59. The Arthur and Sonia Labatt Brain Tumour Research Centre and the Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada
  60. Department of Surgery, University of Toronto, Toronto, Ontario, Canada
  61. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
  62. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
  63. Department of Neurosurgery and Neuro‐oncology, National Cancer Center Hospital, Tokyo, Japan
  64. Department of Neurosurgery, Teikyo University Hospital, Mizonokuchi, Japan
  65. Department of Neurosurgery, Juntendo University, Tokyo, Japan
  66. Department of Pediatric Neurosurgery, Osaka City General Hospital, Osaka, Japan
  67. Department of Neurosurgery, NHO Osaka National Hospital, Osaka, Japan
Institutions: Kyoto University (Japan); Osaka National Hospital (Japan); Saitama Children's Medical Center (Japan); Kyorin University (Japan); Saitama Medical University (Japan); Public Tomioka General Hospital (Japan); Osaka City General Hospital (Japan); Osaka International Cancer Institute (Japan); The University of Osaka (Japan); Yukioka Hospital (Japan); Kanagawa Children's Medical Center (Japan); Kumamoto University (Japan); Saitama International Medical Center (Japan); Kyushu University (Japan); Gunma University (Japan); Hokkaido University (Japan); Tohoku University (Japan); University of Toyama (Japan); Jikei University School of Medicine (Japan); Shizuoka Children's Hospital (Japan); Kobe Children's Hospital (Japan); Fujita Health University (Japan); Okayama University (Japan); Chiba Children's Hospital (Japan); Wakayama Medical University (Japan); Keio University (Japan); Fukushima Medical University (Japan); University of Tsukuba (Japan); Takatsuki General Hospital (Japan); Kanazawa Medical University (Japan); Kansai Medical University (Japan); Nara Medical University (Japan); SHOWA Medical University (Japan); Nippon Medical School (Japan); Nagano Children's Hospital (Japan); Hokkaido Medical Center for Child Health and Rehabilitation (Japan); Kitano Hospital (Japan); Social Insurance Saitama Chuo Hospital (Japan); Osaka Metropolitan University (Japan); Kanazawa University (Japan); University of Occupational and Environmental Health Japan (Japan); Shimane University (Japan); University of Shimane (Japan); Nippon Medical School Musashi Kosugi Hospital (Japan); Kobe University (Japan); Kurume University (Japan); Yamagata University (Japan); Nagoya University (Japan); Tokyo Metropolitan Children's Medical Center (Japan); Hamamatsu University (Japan); Hamamatsu University School of Medicine (Japan); Baylor College of Medicine (United States); Texas Children's Hospital (United States); Dan L Duncan Comprehensive Cancer Center; National Cancer Centre Japan (Japan); Teikyo University Hospital, Mizonokuchi; Juntendo University (Japan)
Journal: Brain pathology (Zurich, Switzerland), volume 36, issue 5, article e70092
Dates: received 23 October 2025; accepted 26 February 2026; published online 11 March 2026; in print September 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1111/bpa.70092 · PMID 41808532 · PMCID PMC13429296 · OpenAlex W7134925918
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: genetics / omics (modality), human (organism), other condition (population)
Methods: Statistics, Connectivity
Keywords: medulloblastoma, methylation analysis, molecular diagnosis, multiplex ligation‐dependent probe amplification, risk stratification
MeSH: Cerebellar Neoplasms*, Medulloblastoma*, Adolescent, Biomarkers, Tumor, Child, Child, Preschool, Cohort Studies, DNA Methylation, East Asian People, Female, Gene Expression Profiling, Humans, Infant, Japan, Male, Mutation, Prognosis (* major topic)
Topic: Glioma Diagnosis and Treatment (Genetics, Medicine), according to OpenAlex
Funding: Japan Agency for Medical Research and Development (AMED) (JP19ck0106330); Japan Agency for Medical Research and Development (JP19ck0106330)
Citations: not cited yet (Europe PMC); 53 references in the paper
Notices: A correction to this paper has been published (42768843, from Europe PMC)

Abstract

Medulloblastoma (MB) is a biologically and clinically heterogeneous pediatric brain tumor. However, large‐scale molecular subgrouping studies have mainly been conducted in Western populations, and comprehensive data from Asia are limited. To address this gap, we analyzed 242 MB cases collected from 39 institutions through the Japan Pediatric Molecular Neuro‐Oncology Group, performing centralized molecular classification using NanoString‐based gene expression profiling, DNA methylation arrays, and multiplex ligation‐dependent probe amplification (MLPA)‐based copy number profiling, supplemented by targeted sequencing. The subgroup distribution was 16.1% WNT, 24.8% SHH, 17.4% Group 3, and 41.7% Group 4. CTNNB1 mutations and monosomy 6 characterized all WNT cases, whereas MYCN amplification and TP53 mutations were independent adverse markers in SHH MB. Group 3 showed the worst survival, with MYC amplification and metastasis as poor prognostic factors. In Group 4, large cell/anaplastic histology predicted poor outcomes, whereas chromosome 11 loss was correlated with a favorable prognosis. Whole chromosomal aberration‐defined favorable‐risk patterns consistently indicate improved outcomes in non‐WNT/non‐SHH MBs. We also developed a simplified MLPA‐based classifier targeting six loci on chromosomes 7, 8, and 11 (SEE‐6‐CNA), which enabled robust and clinically feasible prognostic stratification. Overall, our findings confirm that the molecular subgroup‐specific features of Japanese MBs are largely concordant with global observations and that SEE‐6‐CNA provides a cost‐effective tool to support individualized treatment planning, particularly in resource‐limited settings.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Other data links

Data availability statement

The raw DNA methylation array data (IDAT files) generated in this study were deposited in the NCBI Gene Expression Omnibus (GEO) under the accession number GSE313522 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313522). In contrast, the clinical datasets and other individual‐level molecular data generated and analyzed in the current study are not publicly available due to ethical restrictions and concerns regarding patient privacy.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 71 authors, 5 keywords, 17 MeSH terms, 2 funders, 51 references, 1 integrity notice.

Cite

This paper

Go, K., Katsuma, A., Yoshioka, E., Shofuda, T., Fukuoka, K., Ichimura, K., Matsushita, Y., Mineharu, Y., Makino, Y., Kawauchi, T., Sasaki, A., Hirato, J., Inoue, T., Kodama, Y., Mano, M., Kanematsu, D., Kijima, N., Kagawa, N., Keino, D., . . . Kanemura, Y. (2026). Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods. Brain pathology (Zurich, Switzerland), 36(5), e70092. https://doi.org/10.1111/bpa.70092

BibTeX

@article{go2026molecular,
author = {Go, Kohichi and Katsuma, Asako and Yoshioka, Ema and Shofuda, Tomoko and Fukuoka, Kohei and Ichimura, Koichi and Matsushita, Yuko and Mineharu, Yohei and Makino, Yasuhide and Kawauchi, Takeshi and Sasaki, Atsushi and Hirato, Junko and Inoue, Takeshi and Kodama, Yoshinori and Mano, Masayuki and Kanematsu, Daisuke and Kijima, Noriyuki and Kagawa, Naoki and Keino, Dai and Mukasa, Akitake and Suzuki, Tomonari and Yoshimoto, Koji and Kuga, Daisuke and Horiguchi, Keishi and Yamaguchi, Shigeru and Kanamori, Masayuki and Yamasaki, Kai and Ishibashi, Kenichi and Akai, Takuya and Yamaoka, Masayoshi and Ishizaki, Ryuji and Kawamura, Atsufumi and Ohba, Shigeo and Ishida, Joji and Ando, Ryo and Fukai, Junya and Miwa, Tomoru and Fujii, Masazumi and Muroi, Ai and Saito, Kuniaki and Harada, Atsuko and Hayashi, Yasuhiko and Nonaka, Masahiro and Park, Young‐Soo and Kobayashi, Yusuke and Higuchi, Tadashi and Miyairi, Yosuke and Yoshifuji, Kazuhisa and Takebe, Noriyoshi and Oya, Soichi and Nakajo, Kosuke and Nakada, Mitsutoshi and Nakano, Yoshiteru and Kambara, Mizuki and Adachi, Koji and Tanaka, Kazuhiro and Nakamura, Hideo and Sonoda, Yukihiko and Saito, Ryuta and Wataya, Takafumi and Kurozumi, Kazuhiko and Taylor, Michael D and Narita, Yoshitaka and Shibui, Soichiro and Arai, Hajime and Sakamoto, Hiroaki and Date, Isao and Nagane, Motoo and Nishikawa, Ryo and Arakawa, Yoshiki and Kanemura, Yonehiro},
title = {{Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods}},
journal = {Brain pathology (Zurich, Switzerland)},
year = {2026},
month = mar,
volume = {36},
number = {5},
pages = {e70092},
publisher = {Wiley},
issn = {1015-6305},
doi = {10.1111/bpa.70092},
url = {https://doi.org/10.1111/bpa.70092},
pmid = {41808532},
pmcid = {PMC13429296}
}

RIS

TY - JOUR
AU - Go, Kohichi
AU - Katsuma, Asako
AU - Yoshioka, Ema
AU - Shofuda, Tomoko
AU - Fukuoka, Kohei
AU - Ichimura, Koichi
AU - Matsushita, Yuko
AU - Mineharu, Yohei
AU - Makino, Yasuhide
AU - Kawauchi, Takeshi
AU - Sasaki, Atsushi
AU - Hirato, Junko
AU - Inoue, Takeshi
AU - Kodama, Yoshinori
AU - Mano, Masayuki
AU - Kanematsu, Daisuke
AU - Kijima, Noriyuki
AU - Kagawa, Naoki
AU - Keino, Dai
AU - Mukasa, Akitake
AU - Suzuki, Tomonari
AU - Yoshimoto, Koji
AU - Kuga, Daisuke
AU - Horiguchi, Keishi
AU - Yamaguchi, Shigeru
AU - Kanamori, Masayuki
AU - Yamasaki, Kai
AU - Ishibashi, Kenichi
AU - Akai, Takuya
AU - Yamaoka, Masayoshi
AU - Ishizaki, Ryuji
AU - Kawamura, Atsufumi
AU - Ohba, Shigeo
AU - Ishida, Joji
AU - Ando, Ryo
AU - Fukai, Junya
AU - Miwa, Tomoru
AU - Fujii, Masazumi
AU - Muroi, Ai
AU - Saito, Kuniaki
AU - Harada, Atsuko
AU - Hayashi, Yasuhiko
AU - Nonaka, Masahiro
AU - Park, Young‐Soo
AU - Kobayashi, Yusuke
AU - Higuchi, Tadashi
AU - Miyairi, Yosuke
AU - Yoshifuji, Kazuhisa
AU - Takebe, Noriyoshi
AU - Oya, Soichi
AU - Nakajo, Kosuke
AU - Nakada, Mitsutoshi
AU - Nakano, Yoshiteru
AU - Kambara, Mizuki
AU - Adachi, Koji
AU - Tanaka, Kazuhiro
AU - Nakamura, Hideo
AU - Sonoda, Yukihiko
AU - Saito, Ryuta
AU - Wataya, Takafumi
AU - Kurozumi, Kazuhiko
AU - Taylor, Michael D
AU - Narita, Yoshitaka
AU - Shibui, Soichiro
AU - Arai, Hajime
AU - Sakamoto, Hiroaki
AU - Date, Isao
AU - Nagane, Motoo
AU - Nishikawa, Ryo
AU - Arakawa, Yoshiki
AU - Kanemura, Yonehiro
TI - Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods
T2 - Brain pathology (Zurich, Switzerland)
J2 - Brain Pathol
PY - 2026
DA - 2026/03/11
VL - 36
IS - 5
SP - e70092
SN - 1015-6305
PB - Wiley
DO - 10.1111/bpa.70092
UR - https://doi.org/10.1111/bpa.70092
LA - en
ER -

CSL-JSON

{
"id": "10.1111/bpa.70092",
"type": "article-journal",
"title": "Molecular and clinical features of a Japanese medulloblastoma cohort: Subgroup-specific prognostic stratification using economical/accessible diagnostic methods",
"container-title": "Brain pathology (Zurich, Switzerland)",
"author": [
{
"family": "Go",
"given": "Kohichi"
},
{
"family": "Katsuma",
"given": "Asako"
},
{
"family": "Yoshioka",
"given": "Ema"
},
{
"family": "Shofuda",
"given": "Tomoko"
},
{
"family": "Fukuoka",
"given": "Kohei"
},
{
"family": "Ichimura",
"given": "Koichi"
},
{
"family": "Matsushita",
"given": "Yuko"
},
{
"family": "Mineharu",
"given": "Yohei"
},
{
"family": "Makino",
"given": "Yasuhide"
},
{
"family": "Kawauchi",
"given": "Takeshi"
},
{
"family": "Sasaki",
"given": "Atsushi"
},
{
"family": "Hirato",
"given": "Junko"
},
{
"family": "Inoue",
"given": "Takeshi"
},
{
"family": "Kodama",
"given": "Yoshinori"
},
{
"family": "Mano",
"given": "Masayuki"
},
{
"family": "Kanematsu",
"given": "Daisuke"
},
{
"family": "Kijima",
"given": "Noriyuki"
},
{
"family": "Kagawa",
"given": "Naoki"
},
{
"family": "Keino",
"given": "Dai"
},
{
"family": "Mukasa",
"given": "Akitake"
},
{
"family": "Suzuki",
"given": "Tomonari"
},
{
"family": "Yoshimoto",
"given": "Koji"
},
{
"family": "Kuga",
"given": "Daisuke"
},
{
"family": "Horiguchi",
"given": "Keishi"
},
{
"family": "Yamaguchi",
"given": "Shigeru"
},
{
"family": "Kanamori",
"given": "Masayuki"
},
{
"family": "Yamasaki",
"given": "Kai"
},
{
"family": "Ishibashi",
"given": "Kenichi"
},
{
"family": "Akai",
"given": "Takuya"
},
{
"family": "Yamaoka",
"given": "Masayoshi"
},
{
"family": "Ishizaki",
"given": "Ryuji"
},
{
"family": "Kawamura",
"given": "Atsufumi"
},
{
"family": "Ohba",
"given": "Shigeo"
},
{
"family": "Ishida",
"given": "Joji"
},
{
"family": "Ando",
"given": "Ryo"
},
{
"family": "Fukai",
"given": "Junya"
},
{
"family": "Miwa",
"given": "Tomoru"
},
{
"family": "Fujii",
"given": "Masazumi"
},
{
"family": "Muroi",
"given": "Ai"
},
{
"family": "Saito",
"given": "Kuniaki"
},
{
"family": "Harada",
"given": "Atsuko"
},
{
"family": "Hayashi",
"given": "Yasuhiko"
},
{
"family": "Nonaka",
"given": "Masahiro"
},
{
"family": "Park",
"given": "Young‐Soo"
},
{
"family": "Kobayashi",
"given": "Yusuke"
},
{
"family": "Higuchi",
"given": "Tadashi"
},
{
"family": "Miyairi",
"given": "Yosuke"
},
{
"family": "Yoshifuji",
"given": "Kazuhisa"
},
{
"family": "Takebe",
"given": "Noriyoshi"
},
{
"family": "Oya",
"given": "Soichi"
},
{
"family": "Nakajo",
"given": "Kosuke"
},
{
"family": "Nakada",
"given": "Mitsutoshi"
},
{
"family": "Nakano",
"given": "Yoshiteru"
},
{
"family": "Kambara",
"given": "Mizuki"
},
{
"family": "Adachi",
"given": "Koji"
},
{
"family": "Tanaka",
"given": "Kazuhiro"
},
{
"family": "Nakamura",
"given": "Hideo"
},
{
"family": "Sonoda",
"given": "Yukihiko"
},
{
"family": "Saito",
"given": "Ryuta"
},
{
"family": "Wataya",
"given": "Takafumi"
},
{
"family": "Kurozumi",
"given": "Kazuhiko"
},
{
"family": "Taylor",
"given": "Michael D"
},
{
"family": "Narita",
"given": "Yoshitaka"
},
{
"family": "Shibui",
"given": "Soichiro"
},
{
"family": "Arai",
"given": "Hajime"
},
{
"family": "Sakamoto",
"given": "Hiroaki"
},
{
"family": "Date",
"given": "Isao"
},
{
"family": "Nagane",
"given": "Motoo"
},
{
"family": "Nishikawa",
"given": "Ryo"
},
{
"family": "Arakawa",
"given": "Yoshiki"
},
{
"family": "Kanemura",
"given": "Yonehiro"
}
],
"container-title-short": "Brain Pathol",
"volume": "36",
"issue": "5",
"page": "e70092",
"DOI": "10.1111/bpa.70092",
"PMID": "41808532",
"PMCID": "PMC13429296",
"ISSN": "1015-6305",
"publisher": "Wiley",
"URL": "https://doi.org/10.1111/bpa.70092",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
11
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s40478-026-02302-1
Ovarian central nervous system-type tumors: integrated neuropathological and methylation-based classification reveals site-related features.
Journal: Acta neuropathologica communications
In common: genetics / omics, other condition, 5 references
[2] doi:10.1038/s12276-026-01732-0
Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression.
Journal: Experimental & molecular medicine
In common: genetics / omics, other condition, 4 references
[3] doi:10.1038/s43856-026-01454-4
An interpretable machine learning model for predicting prognosis of medulloblastoma integrating genetic and clinical features.
Journal: Communications medicine
In common: other condition, 4 references
[4] doi:10.1007/s12017-026-08935-8
Subgroup-Specific Associations of GRIA Genes Encoding AMPA Glutamate Receptor Subunits with Patient Survival in Medulloblastoma.
Journal: Neuromolecular medicine
In common: genetics / omics, other condition, 3 references
[5] doi:10.1038/s41467-026-74782-7
Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8<sup>+</sup> T cell responses and promoting tertiary lymphoid structure formation.
Journal: Nature communications
In common: other condition, author Yohei Mineharu
[6] doi:10.7150/ijbs.116040
Elucidating Tumorigenesis Mechanisms and Assessing Immunotherapeutic Efficacy in Patient-Derived Medulloblastoma Organoid Models.
Journal: International journal of biological sciences
In common: genetics / omics, other condition, 3 references
[7] doi:10.1186/s40478-026-02382-z
Methylation profiling and alternative classification approaches in a glioma-enriched FFPE stereotaxic biopsy cohort.
Journal: Acta neuropathologica communications
In common: genetics / omics, other condition, 3 references
[8] doi:10.1186/s40478-026-02269-z
Histological grade 2 and non-contrast-enhancing phenotype provide prognostic information complementary to DNA methylation classification in TERTp-mutant molecular glioblastomas.
Journal: Acta neuropathologica communications
In common: genetics / omics, other condition, 3 references
[9] doi:10.1038/s41586-026-10631-3 [code]
A prognostic human brain network for diffuse midline glioma.
Journal: Nature
In common: other condition, 3 references
[10] doi:10.3390/cells15050474
Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance.
Journal: Cells
In common: genetics / omics, other condition, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.